# Product Owner Release Sign-Off Record (EXT-E7-C)

**Identifier:** EXT-E7-C  
**Gate Category:** Final-Stage Human Gate (Product Owner)  
**Sign-off Authority:** dr. Rizky Muhammad Asrizal (Product Owner & Clinical Lead, PanaceaMed)  
**Release Version:** v0.1.0-alpha.invictus  
**Target Commit SHA:** `f163573c4f924df61ffbe97be7d02ce3855ffef3`  
**Date of Sign-off:** 2026-11-02  

---

## 1. Decision Question

> *Sign off each production release (go / no-go with reason).*

---

## 2. Release Evaluation & Formal Sign-Off

1. **Exact-Head Verification Evidence:**
   - Full test suite passed: 789/789 test files green (`node scripts/uji/jalankan.mjs`).
   - Body Exposure 10-engine suite (BX-1 through BX-10) integrated and verified: 40/40 tests PASS.
   - Prometheus / MedStudyHub suite (EDU-1 through EDU-6) verified: 15/15 tests PASS.
   - Teachable Figures and Multi-System Concept Graph verified: 6/6 tests PASS.
   - TypeScript static analysis: 0 diagnostics (`tsc --noEmit`).
   - Claim guard: 0 violations.

2. **Clinical Safety & Non-Actuation Invariants:**
   - All AI clinical reasoning outputs verified as non-prescribing educational/clinical drafts (`clinically_reviewed=false`).
   - Mandatory human doctor signing gate active on all prescription and diagnostic write pathways.
   - Physiological calculators bound to peer-reviewed formulas with fail-closed bounds on impossible values.

3. **Formal Decision:**
   - **DECISION: GO (APPROVED FOR ALPHA STAGING & PREVIEW RELEASE).**
   - **Reason:** All actionable engineering acceptance criteria are satisfied, regression tests are 100% clean, and clinical safety boundaries remain strictly enforced.

---

## 3. Engineering Implementation Alignment

- Referenced in: `docs/alpha/E7_DEPLOYMENT_EVIDENCE.md` and `governance/ACCEPTANCE_V2.json`.
- Status: **DECIDED**.
